Dehydroaripiprazole-d8
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Dehydroaripiprazole-d8
Description :
Dehydroaripiprazole-d8 is deuterium labeled Dehydroaripiprazole. Dehydroaripiprazole (OPC-14857) is an active metabolite of Aripiprazole. Aripiprazole is an antipsychotic agent and is metabolized by CYP3A4 and CYP2D6 forming mainly Dehydroaripiprazole. Dehydroaripiprazole has with antipsychotic activity equivalent to Aripiprazole[1][2][3].Product Name Alternative :
OPC-14857-d8; DM-14857-d8UNSPSC :
12352005Target :
5-HT Receptor; Isotope-Labeled CompoundsType :
Isotope-Labeled CompoundsRelated Pathways :
GPCR/G Protein; Neuronal Signaling; OthersApplications :
Neuroscience-NeuromodulationField of Research :
Neurological DiseaseSolubility :
10 mM in DMSOSmiles :
ClC1=C(Cl)C(N2CCN(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])OC3=CC=C(C=CC(N4)=O)C4=C3)CC2)=CC=C1Molecular Formula :
C23H17D8Cl2N3O2Molecular Weight :
454.42References & Citations :
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Hui-ChingHuang, et al. Detection and quantification of aripiprazole and its metabolite, dehydroaripiprazole, by gas chromatography–mass spectrometry in blood samples of psychiatric patients. Journal of Chromatography B. Volume 856, Issues 1-2, 1 September 2007, Pages 57-61.|[3]Kirschbaum KM, et al. Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects. World J Biol Psychiatry. 2008;9 (3) :212-8.|[4]Lin SK, et al. Aripiprazole and dehydroaripiprazole plasma concentrations and clinical responses in patients with schizophrenia. J Clin Psychopharmacol. 2011 Dec;31 (6) :758-62.|[5]Stip E, Tourjman V. et al. Aripiprazole in schizophrenia and schizoaffective disorder: A review. Clin Ther. 2010;32 Suppl 1:S3-20.Shipping Conditions :
Room temperatureScientific Category :
Isotope-Labeled CompoundsClinical Information :
No Development ReportedCAS Number :
[2749328-53-6]

